The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Planning and Evaluation (ASPE) released a report on competition in prescription drug markets from 2017 to 2022. ASPE notes that President Biden’s Executive Order on Promoting Competition in the American Economy identified a lack of competition as a key driver for problems across the economic sector. This… (McClurg, December 11, 2023) #Drug Pricing, #Generic Drugs